Skip to main navigation Skip to search Skip to main content

Injectable Multistage Nanovectors for Enhancing Imaging Contrast and Directed Therapy

Biana Godin, Rita Serda, Xuewu Liu, Mauro Ferrari

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Nanovectors are powerful tools for the systemic delivery of therapeutic and imaging agents in oncology. We have recently introduced multistage nanovectors (MSV), designed to overcome sequential biological barriers. The first stage, comprised of porous silicon microparticles, targets tumor-associated endothelium. Once arrested at the disease site, second-stage nanoparticles carrying the therapeutic and imaging agents are released into the tumor microenvironment by time-dependent degradation of the silicon carrier. Particles–cell interactions and degradation of MSV can be controlled by means of particle surface modifications. In this chapter, we will describe studies related to the MSV, focusing on fabrication, intracellular multisite trafficking, advanced therapeutic systems, and contrast agents.

Original languageEnglish (US)
Title of host publicationNanostructure Science and Technology
PublisherSpringer Publishing Company
Pages201-223
Number of pages23
ISBN (Electronic)978-1-4614-2305-8
ISBN (Print)978-1-4614-2304-1
DOIs
StatePublished - 2012

Publication series

NameNanostructure Science and Technology
VolumePart F9881
ISSN (Print)1571-5744
ISSN (Electronic)2197-7976

Keywords

  • Hydrogen Fluoride
  • Iron Oxide Nanoparticles
  • Porous Silicon
  • Silicon Nitride
  • Silicon Particle

ASJC Scopus subject areas

  • General Materials Science
  • Physics and Astronomy (miscellaneous)
  • Chemistry (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Medicine (miscellaneous)

Fingerprint

Dive into the research topics of 'Injectable Multistage Nanovectors for Enhancing Imaging Contrast and Directed Therapy'. Together they form a unique fingerprint.

Cite this